Safety, tolerability and efficacy of the addition of bevacizumab to oxaliplatin/fluoropyrimidine regimens as first-line treatment of metastatic colorectal cancer (mCRC): Results of TREE 2 cohort of the TREE study

被引：0
|
作者：
Hochster, H.
Hart, L.
Ramanathan, R. K.
Hainsworth, J.
Griffing, S.
Mass, R.
Nagarwala, Y.
Jirau-Lucca, G.
Shpilsky, A.
Childs, B. H.
机构：
[1] NYU, Inst Canc, New York, NY USA
[2] Florida Canc Specialist, Ft Myers, FL USA
[3] Univ Pittsburgh, Ctr Canc, Pittsburgh, PA 15260 USA
[4] Sarah Cannon Canc Ctr, Nashville, TN USA
[5] Genentech Inc, San Francisco, CA USA
[6] Sanofi Aventis, Bridgewater, MA USA
来源：
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：173 / 173
页数：1
相关论文
共 50 条
  • [31] RETROSPECTIVE STUDY TO EVALUATE EFFICACY AND SAFETY OF BEVACIZUMAB IN COMBINATION WITH BIWEEKLY XELIRI AS FIRST-LINE TREATMENT IN METASTATIC COLORECTAL CANCER
    Garcia Alfonso, P.
    Alvarez Suarez, S.
    Munoz Martin, A.
    Gonzalez del Val, R.
    Gutirrez Cabezon, L.
    Jerez Gilarranz, Y.
    Marquez-Rodas, I.
    Soria Lobelle, A.
    Riesco Martinez, M. C.
    Adeva Alfonso, J.
    ANNALS OF ONCOLOGY, 2010, 21 : I50 - I50
  • [32] BEVACIZUMAB IN COMBINATION WITH IRINOTECANAND CAPECITABINE AS FIRST-LINE TREATMENT FOR MCRC - EFFICACY AND SAFETY
    Sasa, Jungic
    Gordana, Kecman Malcic
    Ivanka, Rakita
    Dusan, Jovanovic
    Radoslav, Gajanin
    Zdravko, Maric
    Biljana, Tubic
    Zdenka, Gojkovic
    ANNALS OF ONCOLOGY, 2014, 25
  • [33] Effectiveness and safety of second-line (2L) irinotecan- and oxaliplatin-based regimens after first-line (1L) bevacizumab (BV)-containing treatment (tx) for metastatic colorectal cancer (mCRC): Results from the ARIES observational cohort study.
    Bekaii-Saab, Tanios S.
    Grothey, Axel
    Bendell, Johanna C.
    Kozloff, Mark
    Cohn, Allen Lee
    Mun, Yong
    Fish, Susan
    Flick, Elizabeth Dawn
    Dalal, Darshan
    Hurwitz, Herbert
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [34] Microsatellite instability and sensitivity to fluoropyrimidine and oxaliplatin containing first-line chemotherapy in metastatic colorectal cancer
    Liu, Jia
    Wang, Biao
    Fang, Wentong
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2020, 27 (05) : 267 - 270
  • [35] EFFICACY AND SAFETY OF BEVACIZUMAB IN METASTATIC COLORECTAL CANCER (MCRC): FIRST-LINE ANALYSIS OF POOLED DATA FROM RANDOMIZED CONTROLLED TRIALS (RCTS)
    Kabbinavar, F. F.
    Hurwitz, H. I.
    Tebbutt, N. C.
    Giantonio, B. J.
    Guan, Z.
    Mitchell, L.
    Waterkamp, D.
    Tabernero, J.
    ANNALS OF ONCOLOGY, 2012, 23 : 189 - 189
  • [36] The efficacy and safety of capecitabine plus bevacizumab combination as first-line treatment in elderly metastatic colorectal cancer patients
    M. Ozcelik
    H. Odabas
    O. Ercelep
    S. Yuksel
    A. G. Mert
    D. Aydin
    H. Surmeli
    D. Isik
    S. Isik
    A. Oyman
    B. B. Oven Ustaalioglu
    M. Aliustaoglu
    M. Gumus
    Clinical and Translational Oncology, 2016, 18 : 617 - 624
  • [37] The efficacy and safety of capecitabine plus bevacizumab combination as first-line treatment in elderly metastatic colorectal cancer patients
    Ozcelik, M.
    Odabas, H.
    Ercelep, O.
    Yuksel, S.
    Mert, A. G.
    Aydin, D.
    Surmeli, H.
    Isik, D.
    Isik, S.
    Oyman, A.
    Ustaalioglu, B. B. Oven
    Aliustaoglu, M.
    Gumus, M.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (06): : 617 - 624
  • [38] First-line bevacizumab (REV) and chemotherapy (CT) for metastatic colorectal cancer (mCRC); Results from a developing nation
    Franke, F. A.
    Azevedo, S. J.
    Gampel, O.
    Guimaraes, J. Q.
    Schaum, M. R.
    Murad, A.
    Coutinho, A. K.
    Oliveira, J. A.
    Matos Neto, J. N.
    Franca, M. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [39] Bevacizumab with chemotherapy for the first-line treatment of metastatic colorectal cancer: "NCI Slovakia" results
    Dolinsky, J.
    Salek, T.
    Hlavata, Z.
    Ivancova, H.
    Risnyovszka, Z.
    Mardiak, J.
    Koza, I
    ANNALS OF ONCOLOGY, 2006, 17 : 70 - 70
  • [40] SAFETY AND EFFICACY OF BEVACIZUMAB WITH FIRST-LINE FOLFIRI FOR METASTATIC COLORECTAL CANCER: SINGLE CENTER EXPERIENCE
    De Sanctis, R.
    Longo, F.
    Gori, B.
    Zivi, A.
    Del Signore, E.
    Proietti, E.
    De Filippis, L.
    Stumbo, L.
    Quadrini, S.
    Di Seri, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 145 - 145
12345